Literature DB >> 26690779

Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis.

Carla Roberta Nunes Polachini1, Roselia Maria Spanevello2, Daniela Zanini3, Jucimara Baldissarelli3, Luciane Belmonte Pereira3, Maria Rosa Chitolina Schetinger3, Ivana Beatrice Mânica da Cruz3,4,5, Charles Elias Assmann5, Margarete Dulce Bagatini6, Vera Maria Morsch7.   

Abstract

Multiple sclerosis (MS) is an autoimmune neurological disorder of unknown etiology. Oxidative stress and alterations in vitamin D levels have been implicated in the pathophysiology of MS. The aim of this study was to investigate δ-aminolevulinate dehydratase (δ-ALA-D) activity as well as the levels of vitamin D, lipid peroxidation levels, carbonyl protein content, DNA damage, superoxide dismutase (SOD) and catalase (CAT) activities, and the vitamin C, vitamin E, and non-protein thiol (NPSH) content in samples from patients with the relapsing-remitting form of MS (RRMS). The study population consisted of 29 RRMS patients and 29 healthy subjects. Twelve milliliters of blood was obtained from each individual and used for biochemical determinations. The results showed that δ-ALA-D and CAT activities were significantly increased, while SOD activity was decreased in the whole blood of RRMS patients compared to the control group (P < 0.05). In addition, we observed a significant increase in lipid peroxidation, carbonyl protein levels in serum and damaged DNA in leucocytes in RRMS patients compared with the control group (P < 0.05). Nonetheless, the levels of vitamin C, vitamin E, NPSH, and vitamin D were significantly decreased in RRMS patients in relation to the healthy individuals (P < 0.05). In conclusion, our results suggested that the increase in δ-ALA-D activity may be related to the inflammatory and immune process in MS in an attempt to maintain the cellular metabolism and reduce oxidative stress. Moreover, the alterations in the oxidant/antioxidant balance and lower vitamin D levels may contribute to the pathophysiology of MS.

Entities:  

Keywords:  Antioxidant; Multiple sclerosis; Oxidative stress; Vitamin D; δ-Aminolevulinate dehydratase

Mesh:

Substances:

Year:  2015        PMID: 26690779     DOI: 10.1007/s12640-015-9584-2

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  87 in total

1.  Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop.

Authors:  A Hartmann; E Agurell; C Beevers; S Brendler-Schwaab; B Burlinson; P Clay; A Collins; A Smith; G Speit; V Thybaud; R R Tice
Journal:  Mutagenesis       Date:  2003-01       Impact factor: 3.000

Review 2.  Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview.

Authors:  Marianna Mazza; Massimiliano Pomponi; Luigi Janiri; Pietro Bria; Salvatore Mazza
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-08-28       Impact factor: 5.067

3.  A fluorometric micromethod for serum vitamins A and E.

Authors:  L G Hansen; W J Warwick
Journal:  Tech Bull Regist Med Technol       Date:  1969-03

4.  Improved analysis of malondialdehyde in human body fluids.

Authors:  A M Jentzsch; H Bachmann; P Fürst; H K Biesalski
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

5.  Serum arsenic and lipid peroxidation levels in patients with multiple sclerosis.

Authors:  Bahman Yousefi; Yasin Ahmadi; Amir Ghorbanihaghjo; Zeinab Faghfoori; Vahid Shafiei irannejad
Journal:  Biol Trace Elem Res       Date:  2014-04-10       Impact factor: 3.738

6.  Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity.

Authors:  Salih Ozgocmen; Serpil Bulut; Nevin Ilhan; Arif Gulkesen; Ozge Ardicoglu; Yusuf Ozkan
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

Review 7.  [Oxidative stress in human diseases].

Authors:  Vidosava B Djordjević; Lilika Zvezdanović; Vladan Cosić
Journal:  Srp Arh Celok Lek       Date:  2008-05       Impact factor: 0.207

8.  Multiple sclerosis in children and adolescents: incidence and clinical picture - new insights from the nationwide German surveillance (2009-2011).

Authors:  K Reinhardt; S Weiss; J Rosenbauer; J Gärtner; R von Kries
Journal:  Eur J Neurol       Date:  2014-01-28       Impact factor: 6.089

9.  Oxidative damage in multiple sclerosis lesions.

Authors:  Lukas Haider; Marie T Fischer; Josa M Frischer; Jan Bauer; Romana Höftberger; Gergö Botond; Harald Esterbauer; Christoph J Binder; Joseph L Witztum; Hans Lassmann
Journal:  Brain       Date:  2011-06-07       Impact factor: 13.501

10.  Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Authors:  Sreeram V Ramagopalan; Narelle J Maugeri; Lahiru Handunnetthi; Matthew R Lincoln; Sarah-Michelle Orton; David A Dyment; Gabriele C Deluca; Blanca M Herrera; Michael J Chao; A Dessa Sadovnick; George C Ebers; Julian C Knight
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

View more
  5 in total

Review 1.  New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis.

Authors:  Bożena Adamczyk; Monika Adamczyk-Sowa
Journal:  Oxid Med Cell Longev       Date:  2016-10-18       Impact factor: 6.543

Review 2.  Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?

Authors:  Joanna Kocot; Dorota Luchowska-Kocot; Małgorzata Kiełczykowska; Irena Musik; Jacek Kurzepa
Journal:  Nutrients       Date:  2017-06-27       Impact factor: 5.717

Review 3.  Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.

Authors:  Cecilia Rajda; Dániel Pukoli; Zsuzsanna Bende; Zsófia Majláth; László Vécsei
Journal:  Int J Mol Sci       Date:  2017-02-08       Impact factor: 5.923

4.  Vitamin D deficiency and its association with fatigue and quality of life in multiple sclerosis patients.

Authors:  Yesim Beckmann; Sabiha Türe; Sule Uysal Duman
Journal:  EPMA J       Date:  2019-11-20       Impact factor: 6.543

5.  The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy.

Authors:  Bożena Adamczyk; Sławomir Wawrzyniak; Sławomir Kasperczyk; Monika Adamczyk-Sowa
Journal:  Oxid Med Cell Longev       Date:  2017-09-12       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.